George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,706.80
Bid: 1,707.40
Ask: 1,707.80
Change: 1.60 (0.09%)
Spread: 0.40 (0.023%)
Open: 1,701.60
High: 1,708.60
Low: 1,699.40
Prev. Close: 1,705.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

22 Oct 2014 11:41

UK MIDDAY BRIEFING: Glaxo Looks To Cut More Costs As Profit Slides

Read more
22 Oct 2014 11:28

Glaxo Holds Full Year Expectations, But Launches New Restructuring

Read more
22 Oct 2014 11:23

GlaxoSmithKline holds dividend, eyes IPO of HIV unit

LONDON, Oct 22 (Reuters) - GlaxoSmithKline kept its dividend unchanged for the third quarter, breaking a run of steadily rising payouts, as U.S. pricing pressure on its top-selling lung drug Advair eroded sales and profit. Britain's biggest drugmaker said on Wednesday its 2015 dividend was

Read more
22 Oct 2014 11:16

BUZZ-Glaxo tops FTSE on Q3 earnings beat

** GlaxoSmithKline rises 4.6 pct after reporting Q3 EPS of 27.9p, up 5 pct and above the 24p forecast by analysts. ** Biggest one-day rise for stock since April. ** Top riser on FTSE 100 at 1100 GMT. ** Q3 dividend maintained at 19p/shr FY 2014 div expected to be 80p, up 3 pct,

Read more
22 Oct 2014 10:26

CORRECT: MARKET COMMENT: Earnings Drive Mixed UK Stocks

Read more
22 Oct 2014 10:11

J&J, GSK ready to collaborate on Ebola vaccine work

LONDON, Oct 22 (Reuters) - Drugmakers will work together to accelerate development of an Ebola vaccine and Johnson & Johnson and GlaxSmithKline, both of which have experimental vaccine candidates, have already discussed collaboration. J&J, which aims to have at least 1 million doses of its

Read more
22 Oct 2014 09:54

Wednesday broker round-up UPDATE

Amino Technologies: N+1 Singer moves target price from 93p to 107p upgrading to buy. Anglo American: Liberum Capital reduces target price from 1300p to 1200p retaining its sell recommendation. ARM Holdings: UBS moves target price from 970p to 980p upgrading from neutral to buy. Deutsche Bank cuts t

Read more
22 Oct 2014 09:49

MARKET COMMENT: Earnings Drive Mixed UK Stocks, As BOE Stands Pat

Read more
22 Oct 2014 06:35

MARKET COMMENT: UK Stocks To Open Higher Ahead Of BoE Minutes

Read more
22 Oct 2014 05:14

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
21 Oct 2014 17:24

MSF aims to start drug trials in Ebola clinics next month

* MSF says priority will be treatments already available * Hopes trials can begin in November * MSF would not approve use of placebo in drug trials * Women and children should be included in tests By Daniel Flynn DAKAR, Oct 21 (Reuters) - The medical charity Medecine

Read more
21 Oct 2014 16:18

MARKET COMMENT: UK Stocks Gain As ECB Stimulus Hopes Boost Equities

Read more
21 Oct 2014 15:40

RPT-Tens of thousands expected to get Ebola vaccines from January - WHO

(Repeats to additional clients.) * Clinical trials now under way to yield data on dosage * Health workers should get GSK, NewLink vaccines in Jan * Johnson & Johnson, Russia also have candidate vaccines By Stephanie Nebehay GENEVA, Oct 21 (Reuters) - Tens of thousand

Read more
21 Oct 2014 15:35

Tens of thousands expected to get Ebola vaccines from January - WHO

* Clinical trials now under way to yield data on dosage * Health workers should get GSK, NewLink vaccines in Jan * Johnson & Johnson, Russia also have candidate vaccines By Stephanie Nebehay GENEVA, Oct 21 (Reuters) - Tens of thousands of people in West Africa are expected

Read more
21 Oct 2014 15:11

Wednesday preview: Glaxo, MPC minutes, US CPI all due out

Glaxosmithklline will be among the most high-profile companies to release results on Wendesday as the pharmaceutical giant reports its third-quarter figures. The drugmaker is expected to deliver sales of £5.74bn in the three months to 30 September, down from £6.51bn in the third quarter of 2013. Th

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.